FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/062335 [Registered on: 06/02/2024] Trial Registered Prospectively
Last Modified On: 24/01/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of transdermal ketoprofen patch and transdermal fentanyl patch for pain management in patients undergone caesarean section.  
Scientific Title of Study   Efficacy of transdermal ketoprofen patch versus transdermal fentanyl patch in post caesarean section analgesia- a comparative study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sandip Baheti 
Designation  Professor 
Affiliation  Dr. D. Y. Patil Medical College, Hospital and Research Centre 
Address  Dr. D. Y. Patil medical college, hospital and research centre, Sant Tukaram Nagar, Pimpri, Pune

Pune
MAHARASHTRA
411018
India 
Phone  9822014401  
Fax    
Email  snbacademics12@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sandip Baheti 
Designation  Professor 
Affiliation  Dr. D. Y. Patil Medical College, Hospital and Research Centre 
Address  Dr. D. Y. Patil medical college, hospital and research centre, Sant Tukaram Nagar, Pimpri, Pune

Pune
MAHARASHTRA
411018
India 
Phone  9822014401  
Fax    
Email  snbacademics12@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Sharan M 
Designation  Junior resident 
Affiliation  Dr. D. Y. Patil Medical College, Hospital and Research Centre 
Address  Dr. D. Y. Patil medical college, hospital and research centre, Sant Tukaram Nagar, Pimpri, Pune

Pune
MAHARASHTRA
411018
India 
Phone  9442627264  
Fax    
Email  sharanm025@gmail.com  
 
Source of Monetary or Material Support  
Dr. D. Y. Patil medical college, hospital and research centre, Sant Tukaram Nagar, Pimpri, Pune. 
 
Primary Sponsor  
Name  Dr. D. Y. Patil medical college, hospital and research centre. 
Address  Dr. D. Y. Patil medical college, hospital and research centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune. 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sandip Baheti  Dr. D. Y. Patil medical college, hospital and research centre.  Dept of Anaesthesiology, Ground Floor, Old Building, Dr. D. Y. Patil medical college, hospital and research centre, Sant Tukaram Nagar, Pimpri, Pune
Pune
MAHARASHTRA 
9822014401

snbacademics12@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Sub-commitee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O754||Other complications of obstetric surgery and procedures,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group A  Group A will be premedicated with Transdermal Ketoprofen patch 30mg immediately after Spinal anaesthesia for post-operative pain. Dose: 30mg, Frequency: once, immediately after spinal anaesthesia, Duration: 24 hours. 
Comparator Agent  Group B  Group B will be premedicated with Transdermal Fentanyl patch 25mcg immediately after Spinal anaesthesia for post-operative pain. Dose: 25mcg, Frequency: once, immediately after spinal anaestheesia, Duration: 24hours. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1)Ages between 18-40 years scheduled for elective and emergency caesarean sections.
2)ASA grade I and II fit parturient women.
3)Body mass index (BMI) between 20-25kg/m2.
4)Acceptance of study and signing informed consent.
 
 
ExclusionCriteria 
Details  1)Denial to consent for the study
2)History of NSAIDs allergy and opioid sensitivity.
3)History of opioid abuse.
4)Active peptic ulcer disease within 6 months
5)Major systemic illness like Bronchial Asthma, Epilepsy, COPD, Liver disease, Cardiac disease, Renal disease and Coagulopathy.
6)Contraindications to spinal anaesthesia. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
Verbal Assessment Score(VAS) is lower in Group A. Sedation is low in Group A when compared to Group B.   2hr, 4hr, 8hr, 12hr, 16, 10hr, 24hr.  
 
Secondary Outcome  
Outcome  TimePoints 
Complications like nausea, vomiting, pruritis, erythema and respiratory depression are low in Group A.  2hr, 4hr, 8hr, 12hr, 16, 10hr, 24hr.  
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   14/02/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

AIM:

The primary aim of this research is to compare the efficacy of Transdermal Ketoprofen patch of 30mg versus Transdermal Fentanyl patch of 25mcg in respect to post-operative analgesia, duration of analgesia, patient comfort and satisfaction.

PRIMARY OBJECTIVE:

 To compare the efficacy of Transdermal Ketoprofen  patch 30mg versus Transdermal Fentanyl patch 25mcg for post-operative analgesia in women undergoing Lower Segmental Caesarean Section.

SECONDARY OBJECTIVE:

1)    Patient comfort

2)    Side effects


     INCLUSION CRITERIA:

      Ages between 18-40 years scheduled for elective and emergency caesarean sections.

2)    ASA grade I and II fit parturient women.

3)    Body mass index (BMI) between 20-25kg/m2.

4)    Acceptance of study and signing informed consent.

 

EXCLUSION CRITERIA 

1)    Denial to consent for the study

2)    History of NSAIDs allergy and opioid sensitivity.

3)    History of opioid abuse.

4)    Active peptic ulcer disease within 6 months

5)    Major systemic illness like Bronchial Asthma, Epilepsy, COPD, Liver disease, Cardiac disease, Renal disease and Coagulopathy.

6)    Contraindications to spinal anaesthesia.


     METHODOLOGY:

For all pregnant women in inclusion criteria scheduled for lower segment caesarean sections (LSCS) pre-anesthesia checkup will be done and assessed before surgery. Spinal anaesthesia technique and its complications will be explained before taking consent. An 18G wide bore cannula will be secured to all parturient women. Baseline vitals are recorded in preop using ASA standard monitors. 500 mL of Ringer Lactate as preload, Inj. Pantaprazole 40mg and Inj. Ondansetron 4mg will be given intravenously as premedications.

In the operating room, all standard monitors according to ASA (NIBP, ECG, pulse oximeter) will be connected and values recorded. Parturient will be made to sit with hips flexed and knees extended in the operating table. Under all aseptic precautions, scrubbing with 10% Povidone-iodine done and draped with sterile towel. After palpation of appropriate anatomical landmark (L2-L3 or L3-L4), 2ml of Inj. Lignocaine 2% will be given as local skin infiltration. 26G Quinky’s spinal needle will be introduced in the sub arachnoid space and after confirmation of free flow of cerebrospinal fluid, 2.2ml of 0.5% Inj. Bupivacaine heavy will be injected intrathecally at the rate of 0.2ml/second. Group A parturient will be receiving Transdermal Ketoprofen 30mg patch on hair-free area in the antero-lateral chest wall or upper or at the sides of the waist and mounted in place and covered by adhesive plasters immediately after spinal anaesthesia and  Group B parturient will be receiving Transdermal Fentanyl 25mcg/hr patch on same sites immediately after spinal anaesthesia. Parturient will be made to lie down immediately and the level of block will be assessed using Bromage scale. After an adequate blockade (T6) surgery will be started. NIBP is measured every 3rd minute and intraoperative hypotension is defined as decrease in systolic blood pressure of less than 20% of the baseline value recorded and treated with Inj. Ephedrine 6mg or Inj. Phenylepherine 50-100mg intravenously along with bolus fluids. Bradycardia is defined as heart rate less than less than 50 beats/min and treated according to symptoms appropriately. Immediately after delivery of baby, 10 IU of Inj.Oxytocin will be given along with fluids. Parturient will be monitored and other complications like Nausea, Vomiting, Shivering and patch site irritation will be treated. Once the surgery is completed vitals and level of spinal anaesthesia will be checked and patient will be shifted to Post Anaesthesia Care Unit (PACU). In the PACU all monitors according to ASA will be attached and parameters will be monitored.

Pain assessment, patients comfort and any side effects (nausea, vomiting, erythema, pruritus, sedation, respiratory depression) will be monitored post-operatively. Pain assessment will be done by Visual Analogue Scale (VAS) every 2nd hourly. Patient will be asked to rate their level of pain. A VAS score of 4 and above will be treated with Inj. Tramadol 100mg or Inj. Paracetamol 1g and its frequency will be noted. Sedation score will be measured using Ramsay sedation score (RSS) to all the patients.

 
Close